يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"Hansson, Markus"', وقت الاستعلام: 0.69s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group.

    المؤلفون: Partanen, Anu, Waage, Anders, Peceliunas, Valdas, Schjesvold, Fredrik, Anttila, Pekka, Säily, Marjaana, Uttervall, Katarina, Putkonen, Mervi, Carlson, Kristina, Haukas, Einar, Sankelo, Marja, Szatkowski, Damian, Hansson, Markus, Marttila, Anu, Svensson, Ronald, Axelsson, Per, Lauri, Birgitta, Mikkola, Maija, Karlsson, Conny, Abelsson, Johanna

    المصدر: Cancers; Mar2024, Vol. 16 Issue 5, p1024, 15p

    مصطلحات موضوعية: THERAPEUTIC use of antineoplastic agents, MULTIPLE myeloma treatment, THERAPEUTIC use of protease inhibitors, HEMATOPOIETIC stem cell transplantation, CYTOGENETICS, FLOW cytometry, RESEARCH funding, TREATMENT effectiveness, CANCER patients, DESCRIPTIVE statistics, CARBOCYCLIC acids, LONGITUDINAL method, RESEARCH, FLUORESCENCE in situ hybridization, PROGRESSION-free survival, DATA analysis software, DEXAMETHASONE, SENSITIVITY & specificity (Statistics), OVERALL survival, DISEASE progression, BLOOD protein electrophoresis

    النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group

    المؤلفون: Nielsen, Lene Kongsgaard, Schjesvold, Fredrik, Möller, Sören, Guldbrandsen, Nina, Hansson, Markus, Remes, Kari, Peceliunas, Valdas, Abildgaard, Niels, Gregersen, Henrik, King, Madeleine T.

    المصدر: Journal of Patient-Reported Outcomes; 2/5/2024, Vol. 8, p1-18, 18p

    مصطلحات موضوعية: THERAPEUTIC use of antineoplastic agents, STATISTICS, CONFIDENCE intervals, DEXAMETHASONE, REGRESSION analysis, TREATMENT effectiveness, RANDOMIZED controlled trials, QUALITY of life, KAPLAN-Meier estimator, QUESTIONNAIRES, RESEARCH funding, PROGRESSION-free survival, HEMATOPOIETIC stem cell transplantation, MULTIPLE myeloma, STATISTICAL sampling, DATA analysis, ODDS ratio, OVERALL survival, PROPORTIONAL hazards models

    النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Epidemiology and clinical outcomes of light-chain amyloidosis in Sweden: A nationwide population-based study.

    المؤلفون: Mellqvist, Ulf-Henrik, Qian Cai, Hester, Laura L., Grövdal, Michael, Börsum, Jakob, Rahman, Iffat, Ammann, Eric M., Hansson, Markus

    المصدر: European Journal of Haematology; Nov2023, Vol. 111 Issue 5, p697-705, 9p

    مصطلحات موضوعية: CARDIAC amyloidosis, CLINICAL epidemiology, AMYLOIDOSIS, EVIDENCE gaps, TREATMENT effectiveness, KIDNEY failure

    مصطلحات جغرافية: SWEDEN


    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Impact of 1q gains on treatment outcomes of patients with newly diagnosed multiple myeloma in a real‐world Swedish population receiving modern treatment.

    المؤلفون: Lemonakis, Konstantinos, Olsson‐Arvidsson, Linda, Karlsson, Conny, Johansson, Bertil, Hansson, Markus

    المصدر: European Journal of Haematology; Sep2023, Vol. 111 Issue 3, p391-399, 9p

    مصطلحات موضوعية: MULTIPLE myeloma, TREATMENT effectiveness, MULTIVARIATE analysis, PROGRESSION-free survival, OVERALL survival, PLASMACYTOMA


    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Real-world treatment patterns and outcomes for patients with multiple myeloma in Denmark, Finland and Sweden: An analysis using linked Nordic registries.

    المؤلفون: Abildgaard, Niels1,2 (AUTHOR) niels.abildgaard@rsyd.dk, Anttila, Pekka3 (AUTHOR), Waage, Anders4 (AUTHOR), Rubin, Katrine Hass5 (AUTHOR), Ørstavik, Sigurd6 (AUTHOR), Bent-Ennakhil, Nawal7 (AUTHOR), Gavini, François7 (AUTHOR), Ma, Yuanjun8 (AUTHOR), Freilich, Jonatan8,9 (AUTHOR), Hansson, Markus10 (AUTHOR)

    المصدر: European Journal of Cancer. Apr2024, Vol. 201, pN.PAG-N.PAG. 1p.

    مصطلحات موضوعية: *THERAPEUTIC use of antineoplastic agents, *MULTIPLE myeloma treatment, *HEMATOPOIETIC stem cell transplantation, *MULTIPLE myeloma, *DRUG resistance in cancer cells, *THALIDOMIDE, *TREATMENT effectiveness, *CANCER patients, *PREDNISOLONE, *CANCER chemotherapy, *BORTEZOMIB, *CARBOCYCLIC acids, *MELPHALAN, *PHYSICIAN practice patterns, *DRUG prescribing, *TIME, *OVERALL survival, *EVALUATION

    مصطلحات جغرافية: FINLAND, SWEDEN, DENMARK


    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma.

    المؤلفون: Dimopoulos, Meletios A.1 mdimop@med.uoa.gr, Grosicki, Sebastian2 sgrosicki@wp.pl, Jędrzejczak, Wiesław W.3 wieslaw.jedrzejczak@wum.edu.pl, Nahi, Hareth4 hareth.nahi@sll.se, Gruber, Astrid4 astridgruber7@gmail.com, Hansson, Markus5,6 markus.hansson@med.lu.se, Gupta, Neeraj7 neeraj.gupta@takeda.com, Byrne, Catriona7 Catriona.Byrne@takeda.com, Labotka, Richard7 Richard.labotka@takeda.com, Teng, Zhaoyang7 zhaoyang.teng2@takeda.com, Yang, Huyuan7 Huyuan.Yang@takeda.com, Grzasko, Norbert8,9 norbertgrzasko@gmail.com, Kumar, Shaji10 kumar.shaji@mayo.edu

    المصدر: European Journal of Cancer. Jan2019, Vol. 106, p89-98. 10p.

    مصطلحات موضوعية: *THERAPEUTIC use of protease inhibitors, *COMBINATION drug therapy, *MULTIPLE myeloma, *NEUTROPENIA, *PROTEASE inhibitors, *RANDOMIZED controlled trials, *TREATMENT effectiveness, *PATIENT selection, *DEXAMETHASONE, *CYCLOPHOSPHAMIDE, *TREATMENT duration, *PROGNOSIS


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث